Market closed · Oct 8, 7:20 am ET · Last extended-hours $6.80 -0.15%
Open$6.87
Prev close$6.78
Day range$6.60 – $7.03
Volume1.63M
Market cap$550.94M
P/E (TTM)–
Dividend yield–
PHAT Stock News
Headlines matching Phathom Pharmaceuticals or the PHAT ticker, most recent first.
Leerink Partners Initiates Phathom Pharmaceuticals(PHAT.US) With Hold Rating, Announces Target Price $10Market news · 9 Sep 2026 · Direct mention
H.C. Wainwright Keeps Their Buy Rating on Phathom Pharmaceuticals (PHAT)TipRanks · 22 Sep 2026 · Direct mention
H.C. Wainwright Maintains Phathom Pharmaceuticals(PHAT.US) With Buy Rating, Maintains Target Price $26Market news · 22 Sep 2026 · Direct mention
Barclays Maintains Phathom Pharmaceuticals(PHAT.US) With Buy Rating, Cuts Target Price to $14NegativeMarket news · 17 Aug 2026 · Direct mention
Raymond James Maintains Phathom Pharmaceuticals(PHAT.US) With Buy Rating, Cuts Target Price to $21NegativeMarket news · 31 Jul 2026 · Direct mention
Craig-Hallum Maintains Phathom Pharmaceuticals(PHAT.US) With Buy Rating, Announces Target Price $20Market news · 31 Jul 2026 · Direct mention
Needham Maintains Phathom Pharmaceuticals(PHAT.US) With Buy Rating, Cuts Target Price to $22NegativeMarket news · 31 Jul 2026 · Direct mention
Guggenheim Maintains Phathom Pharmaceuticals(PHAT.US) With Buy Rating, Cuts Target Price to $22NegativeMarket news · 31 Jul 2026 · Direct mention
Earnings Flash (PHAT) Phathom Pharmaceuticals, Inc. Posts Q2 Adjusted EPS $0.00 per Share, Vs. FactSet Est of $-0.19MT Newswires · 30 Jul 2026 · Direct mention
Needham Maintains Phathom Pharmaceuticals(PHAT.US) With Buy Rating, Maintains Target Price $28Market news · 22 Jul 2026 · Direct mention
Guggenheim Maintains Phathom Pharmaceuticals(PHAT.US) With Buy Rating, Maintains Target Price $25Market news · 22 Jul 2026 · Direct mention
Craig-Hallum Maintains Phathom Pharmaceuticals(PHAT.US) With Buy RatingMarket news · 14 Jul 2026 · Direct mention
Barclays Maintains Phathom Pharmaceuticals(PHAT.US) With Buy Rating, Maintains Target Price $18Market news · 15 May 2026 · Direct mention
A Quick Look at Today's Ratings for Phathom Pharmaceuticals(PHAT.US), With a Forecast Between $25 to $28Market news · 1 May 2026 · Direct mention
Barclays Upgrades Phathom Pharmaceuticals(PHAT.US) to Buy Rating, Raises Target Price to $18PositiveMarket news · 27 Mar 2026 · Direct mention
Discussion
No comments yet — be the first to weigh in on PHAT.
No comments yet — be the first to weigh in on PHAT.